Cargando…
Assessment of channeling bias among initiators of glucose-lowering drugs: A UK cohort study
BACKGROUND: Channeling bias may occur when a newly marketed drug and an established drug, despite similar indications, are prescribed to patients with different prognostic characteristics (ie, confounding). AIM: To investigate channeling bias and its impact on relative effectiveness of glucagon-like...
Autores principales: | Ankarfeldt, Mikkel Z, Thorsted, Brian L, Groenwold, Rolf HH, Adalsteinsson, Erpur, Ali, M Sanni, Klungel, Olaf H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5261549/ https://www.ncbi.nlm.nih.gov/pubmed/28176886 http://dx.doi.org/10.2147/CLEP.S124054 |
Ejemplares similares
-
A systematic literature review on the efficacy–effectiveness gap: comparison of randomized controlled trials and observational studies of glucose-lowering drugs
por: Ankarfeldt, Mikkel Z, et al.
Publicado: (2017) -
Assessment of channeling bias among initiators of glucose-lowering drugs: A UK cohort study [Corrigendum]
Publicado: (2018) -
Amiodarone use and the risk of acute pancreatitis: Influence of different exposure definitions
por: Hempenius, Mirjam, et al.
Publicado: (2019) -
Benefits of probabilistic sensitivity analysis – a review of NICE decisions
por: Adalsteinsson, Erpur, et al.
Publicado: (2013) -
Selection of confounding variables should not be based on observed associations with exposure
por: Groenwold, Rolf H. H., et al.
Publicado: (2011)